Study of NGX-4010 for Treatment of Painful HIV-Associated Neuropathy

Stopped early · Phase 3

Conditions studied: HIV Infections, Peripheral Nervous System Diseases, Pain

In brief

The purpose of the study is to determine if an investigational drug, NGX-4010 (high-concentration capsaicin patch), is safe, tolerable and effective in treating painful HIV-associated neuropathy.

Key facts

Study ID

NCT00085761

Run by

NeurogesX

Last updated by the study team

2008-03-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• NeurogesX Investigational Site — Sarasota, Florida, United States
• NeurogesX Investigational Site — Annandale, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.